| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 MYH10 MYH11 ATP8A1 NSF MYH14 ABCA12 ABCA13 ATP6V0A4 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 DNAH1 | 8.92e-11 | 614 | 75 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.57e-09 | 109 | 75 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.45e-07 | 178 | 75 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8A1 NSF ABCA12 ABCA13 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 | 7.40e-07 | 441 | 75 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.09e-06 | 49 | 75 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP8A1 PKD2L2 CLCN6 ABCA12 ABCA13 SLC25A1 ATP6V0A4 NIPA1 ASIC5 SLC13A2 ITGAV LRRC8D ABCA10 ABCA9 ATP4A ABCC10 SLC22A31 | 1.32e-06 | 1180 | 75 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP8A1 CLCN6 ABCA12 ABCA13 SLC25A1 ATP6V0A4 SLC13A2 ABCA10 ABCA9 ATP4A ABCC10 | 1.59e-06 | 477 | 75 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | ATP8A1 PKD2L2 CLCN6 ABCA12 ABCA13 SLC25A1 ATP6V0A4 NIPA1 ASIC5 SLC13A2 ITGAV LRRC8D ABCA10 ABCA9 ATP4A ABCC10 SLC22A31 | 4.38e-06 | 1289 | 75 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.41e-06 | 118 | 75 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.23e-05 | 38 | 75 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP8A1 NSF ABCA12 ABCA13 GARS1 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 | 6.39e-05 | 839 | 75 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP8A1 NSF ABCA12 ABCA13 GARS1 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 | 6.46e-05 | 840 | 75 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP8A1 NSF ABCA12 ABCA13 GARS1 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 | 6.46e-05 | 840 | 75 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP8A1 NSF ABCA12 ABCA13 SMC4 DNAH9 ABCA10 ABCA9 ATP4A ABCC10 MOV10 | 1.42e-04 | 775 | 75 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | P-type proton-exporting transporter activity | 6.14e-04 | 10 | 75 | 2 | GO:0008553 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP8A1 PKD2L2 CLCN6 ATP6V0A4 NIPA1 ASIC5 SLC13A2 ITGAV LRRC8D ATP4A | 7.40e-04 | 793 | 75 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.57e-04 | 196 | 75 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.64e-03 | 62 | 75 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.64e-03 | 227 | 75 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.05e-03 | 18 | 75 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | PKD2L2 CLCN6 ATP6V0A4 NIPA1 ASIC5 SLC13A2 ITGAV ATP4A ABCC10 | 2.09e-03 | 758 | 75 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.41e-03 | 664 | 75 | 8 | GO:0008324 | |
| GeneOntologyCellularComponent | myosin II filament | 4.81e-08 | 3 | 77 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | myosin filament | 2.03e-06 | 25 | 77 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 3.26e-06 | 28 | 77 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | brush border | 2.07e-05 | 152 | 77 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | myosin complex | 6.64e-05 | 59 | 77 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.74e-04 | 223 | 77 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.97e-04 | 462 | 77 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.97e-04 | 462 | 77 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | vacuolar membrane | 5.50e-04 | 507 | 77 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 6.07e-04 | 185 | 77 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 6.59e-04 | 107 | 77 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 6.59e-04 | 107 | 77 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | lysosome | ATP8A1 CLCN6 AP2B1 HLA-DOB NSF ABCA13 ACLY SIGLEC6 ATP6V0A4 ABCC10 | 7.64e-04 | 811 | 77 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ATP8A1 CLCN6 AP2B1 HLA-DOB NSF ABCA13 ACLY SIGLEC6 ATP6V0A4 ABCC10 | 7.64e-04 | 811 | 77 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | actomyosin | 9.21e-04 | 117 | 77 | 4 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 9.50e-04 | 118 | 77 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.60e-03 | 230 | 77 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | vacuole | ATP8A1 CLCN6 AP2B1 HLA-DOB NSF ABCA13 ACLY SIGLEC6 ATP6V0A4 ABCC10 | 1.86e-03 | 913 | 77 | 10 | GO:0005773 |
| Domain | ABC_A | 1.22e-07 | 12 | 76 | 4 | IPR026082 | |
| Domain | Myosin_N | 3.34e-07 | 15 | 76 | 4 | PF02736 | |
| Domain | Myosin_N | 3.34e-07 | 15 | 76 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 7.42e-07 | 18 | 76 | 4 | PF01576 | |
| Domain | Myosin_tail | 7.42e-07 | 18 | 76 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 9.37e-07 | 19 | 76 | 4 | IPR027401 | |
| Domain | - | 9.37e-07 | 19 | 76 | 4 | 4.10.270.10 | |
| Domain | P-loop_NTPase | MYH9 MYH10 MYH11 NSF MYH14 ABCA12 ABCA13 SMC4 DNAH9 ABCA10 ABCA9 ABCC10 MOV10 SBNO2 DNAH1 | 1.35e-06 | 848 | 76 | 15 | IPR027417 |
| Domain | ABC_tran | 1.46e-06 | 48 | 76 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.46e-06 | 48 | 76 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.62e-06 | 49 | 76 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 1.79e-06 | 50 | 76 | 5 | IPR003439 | |
| Domain | AAA+_ATPase | 1.96e-06 | 144 | 76 | 7 | IPR003593 | |
| Domain | AAA | 1.96e-06 | 144 | 76 | 7 | SM00382 | |
| Domain | Myosin_head_motor_dom | 1.68e-05 | 38 | 76 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.68e-05 | 38 | 76 | 4 | PS51456 | |
| Domain | Myosin_head | 1.68e-05 | 38 | 76 | 4 | PF00063 | |
| Domain | MYSc | 1.68e-05 | 38 | 76 | 4 | SM00242 | |
| Domain | SAC3/GANP/THP3 | 9.75e-05 | 4 | 76 | 2 | IPR005062 | |
| Domain | SAC3_GANP | 9.75e-05 | 4 | 76 | 2 | PF03399 | |
| Domain | Myosin_S1_N | 1.62e-04 | 5 | 76 | 2 | IPR008989 | |
| Domain | IQ | 2.00e-04 | 71 | 76 | 4 | PF00612 | |
| Domain | - | NSF ABCA12 ABCA13 SMC4 DNAH9 ABCA10 ABCA9 ABCC10 MOV10 SBNO2 DNAH1 | 2.06e-04 | 746 | 76 | 11 | 3.40.50.300 |
| Domain | Beta2_adaptin/TBP_C_dom | 2.43e-04 | 6 | 76 | 2 | IPR012295 | |
| Domain | - | 2.43e-04 | 6 | 76 | 2 | 3.30.310.10 | |
| Domain | IQ | 3.32e-04 | 81 | 76 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.96e-04 | 90 | 76 | 4 | IPR000048 | |
| Domain | IQ | 5.62e-04 | 93 | 76 | 4 | PS50096 | |
| Domain | ABC_transporter_CS | 6.63e-04 | 42 | 76 | 3 | IPR017871 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.44e-03 | 14 | 76 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.44e-03 | 14 | 76 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.44e-03 | 14 | 76 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.44e-03 | 14 | 76 | 2 | PF08393 | |
| Domain | MT | 1.44e-03 | 14 | 76 | 2 | PF12777 | |
| Domain | AAA_8 | 1.44e-03 | 14 | 76 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.44e-03 | 14 | 76 | 2 | IPR011704 | |
| Domain | AAA_5 | 1.44e-03 | 14 | 76 | 2 | PF07728 | |
| Domain | DHC_fam | 1.66e-03 | 15 | 76 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.66e-03 | 15 | 76 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.66e-03 | 15 | 76 | 2 | PF03028 | |
| Domain | HAD-like_dom | 4.10e-03 | 79 | 76 | 3 | IPR023214 | |
| Domain | HR1_rho-bd | 4.61e-03 | 25 | 76 | 2 | IPR011072 | |
| Domain | Rho_GTPase_activation_prot | 5.55e-03 | 88 | 76 | 3 | IPR008936 | |
| Domain | - | 7.49e-03 | 32 | 76 | 2 | 3.40.1110.10 | |
| Domain | - | 7.49e-03 | 32 | 76 | 2 | 2.70.150.10 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.17e-06 | 19 | 61 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.17e-06 | 19 | 61 | 4 | M27489 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.22e-06 | 44 | 61 | 5 | M11911 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.46e-06 | 20 | 61 | 4 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.80e-06 | 21 | 61 | 4 | M27494 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A1 CLCN6 AP2B1 ABCA12 SLC25A1 ATP6V0A4 NIPA1 ASIC5 SLC13A2 LRRC8D ABCA10 ABCA9 ATP4A ABCC10 | 2.25e-06 | 736 | 61 | 14 | M27287 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.64e-06 | 23 | 61 | 4 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 3.16e-06 | 24 | 61 | 4 | M2243 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A1 CLCN6 AP2B1 ABCA12 SLC25A1 ATP6V0A4 NIPA1 ASIC5 SLC13A2 LRRC8D ABCA9 ATP4A ABCC10 | 5.34e-06 | 681 | 61 | 13 | MM14985 |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 6.95e-06 | 29 | 61 | 4 | M27309 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.25e-05 | 70 | 61 | 5 | M12294 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.73e-05 | 92 | 61 | 5 | M27201 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 6.01e-05 | 18 | 61 | 3 | M524 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.66e-04 | 64 | 61 | 4 | M7923 | |
| Pathway | BIOCARTA_MALATEX_PATHWAY | 5.07e-04 | 8 | 61 | 2 | M22038 | |
| Pathway | BIOCARTA_MALATEX_PATHWAY | 5.07e-04 | 8 | 61 | 2 | MM1558 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 6.50e-04 | 9 | 61 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 6.50e-04 | 9 | 61 | 2 | M46436 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 6.95e-04 | 93 | 61 | 4 | M27487 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 8.11e-04 | 10 | 61 | 2 | M48013 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.69e-04 | 176 | 61 | 5 | MM15718 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.02e-03 | 103 | 61 | 4 | M758 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.15e-03 | 183 | 61 | 5 | M997 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 1.39e-03 | 13 | 61 | 2 | M46434 | |
| Pubmed | LENG8 MYH9 MYH10 MYH11 AP2B1 MYH14 ACLY SLC25A1 MCM3AP GARS1 TNRC6A TRIM71 SSR3 SNRNP70 ITGAV PLOD1 MOV10 | 6.35e-09 | 1371 | 77 | 17 | 36244648 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15774463 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20685736 | ||
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 1.04e-08 | 3 | 77 | 3 | 14594953 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15177565 | ||
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 1.04e-08 | 3 | 77 | 3 | 24072716 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15845534 | ||
| Pubmed | 1.08e-08 | 12 | 77 | 4 | 8424456 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.38e-08 | 197 | 77 | 8 | 20811636 | |
| Pubmed | MYH9 MYH10 AP2B1 MYH14 ACLY MCM3AP USP24 SMC4 SNRNP70 PLOD1 HECTD1 MOV10 | 2.10e-08 | 653 | 77 | 12 | 22586326 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH9 MYH10 NSF ACLY TBPL1 NT5DC2 SLC25A1 GARS1 USP24 TNRC6A SMC4 SSR3 SNRNP70 PLOD1 YARS1 MOV10 | 2.56e-08 | 1318 | 77 | 16 | 30463901 |
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 4.17e-08 | 4 | 77 | 3 | 18697221 | |
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 1.04e-07 | 5 | 77 | 3 | 19439495 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 33871354 | ||
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 1.04e-07 | 5 | 77 | 3 | 25006807 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.04e-07 | 5 | 77 | 3 | 11121372 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GORASP2 MYH11 NSF ACLY SLC25A1 USP24 SMC4 PTDSS2 SSR3 PLXNB2 PLOD1 HECTD1 VPS53 | 1.44e-07 | 942 | 77 | 13 | 31073040 |
| Pubmed | 1.58e-07 | 22 | 77 | 4 | 8894702 | ||
| Pubmed | 1.81e-07 | 383 | 77 | 9 | 29331416 | ||
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 2.08e-07 | 6 | 77 | 3 | 22972683 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 15034141 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 30044719 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.43e-07 | 202 | 77 | 7 | 33005030 | |
| Pubmed | Nonmuscle myosin II isoform and domain specificity during early mouse development. | 3.63e-07 | 7 | 77 | 3 | 20679233 | |
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 5.80e-07 | 8 | 77 | 3 | 25848986 | |
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 33424621 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 5.80e-07 | 8 | 77 | 3 | 17429076 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PASK MYH9 MYH10 AP2B1 NSF ACLY TBPL1 SLC25A1 SMC4 CHST12 SSR3 SNRNP70 YARS1 MOV10 | 7.78e-07 | 1284 | 77 | 14 | 17353931 |
| Pubmed | MYH9 MYH10 AP2B1 ACLY RAD1 GARS1 USP24 SMC4 SNRNP70 ITGAV PLXNB2 PLOD1 HECTD1 YARS1 | 8.77e-07 | 1297 | 77 | 14 | 33545068 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 1.24e-06 | 10 | 77 | 3 | 11435397 | |
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 1.24e-06 | 10 | 77 | 3 | 24825879 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.50e-06 | 364 | 77 | 8 | 24778252 | |
| Pubmed | 1.50e-06 | 494 | 77 | 9 | 26831064 | ||
| Pubmed | 2.16e-06 | 266 | 77 | 7 | 19380743 | ||
| Pubmed | 2.31e-06 | 95 | 77 | 5 | 33863777 | ||
| Pubmed | 3.09e-06 | 45 | 77 | 4 | 22114352 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 3.29e-06 | 182 | 77 | 6 | 31067453 | |
| Pubmed | PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium. | 3.73e-06 | 14 | 77 | 3 | 22560610 | |
| Pubmed | 4.35e-06 | 191 | 77 | 6 | 33762435 | ||
| Pubmed | Patterning and folding of intestinal villi by active mesenchymal dewetting. | 4.66e-06 | 15 | 77 | 3 | 38781967 | |
| Pubmed | SIK2 orchestrates actin-dependent host response upon Salmonella infection. | 4.73e-06 | 50 | 77 | 4 | 33947818 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21792479 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22328520 | ||
| Pubmed | Nonmuscle myosin II-B is required for normal development of the mouse heart. | 4.84e-06 | 2 | 77 | 2 | 9356462 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16316347 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25185263 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19109430 | ||
| Pubmed | Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells. | 4.84e-06 | 2 | 77 | 2 | 26136073 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17020881 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22191382 | ||
| Pubmed | Myosin II isoforms play distinct roles in adherens junction biogenesis. | 4.84e-06 | 2 | 77 | 2 | 31486768 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9725909 | ||
| Pubmed | The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells. | 4.84e-06 | 2 | 77 | 2 | 33415745 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23128239 | ||
| Pubmed | Differential localization of myosin-II isozymes in human cultured cells and blood cells. | 4.84e-06 | 2 | 77 | 2 | 7699007 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24807208 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33001861 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33188738 | ||
| Pubmed | Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells. | 4.84e-06 | 2 | 77 | 2 | 20932596 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18843042 | ||
| Pubmed | Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity. | 4.84e-06 | 2 | 77 | 2 | 15880105 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29486156 | ||
| Pubmed | Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue. | 4.84e-06 | 2 | 77 | 2 | 10906735 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8089273 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22025714 | ||
| Pubmed | Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. | 4.84e-06 | 2 | 77 | 2 | 1860190 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29467250 | ||
| Pubmed | Non-muscle myosin IIB is essential for cytokinesis during male meiotic cell divisions. | 4.84e-06 | 2 | 77 | 2 | 22820068 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34374341 | ||
| Pubmed | Nonmuscle myosin II exerts tension but does not translocate actin in vertebrate cytokinesis. | 4.84e-06 | 2 | 77 | 2 | 22393000 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30995168 | ||
| Pubmed | Expression of four myosin heavy chain isoforms with development in mouse uterus. | 4.84e-06 | 2 | 77 | 2 | 8402956 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27737892 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20861308 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28600434 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23732912 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26138142 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12893741 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 7916668 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21106542 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11029059 | ||
| Pubmed | SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling. | 4.84e-06 | 2 | 77 | 2 | 29715457 | |
| Pubmed | New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation. | 4.84e-06 | 2 | 77 | 2 | 30050389 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16596254 | ||
| Pubmed | 6.00e-06 | 202 | 77 | 6 | 24639526 | ||
| Pubmed | 6.46e-06 | 54 | 77 | 4 | 22266860 | ||
| Pubmed | 7.23e-06 | 451 | 77 | 8 | 36168627 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 MYH10 ARAP3 AP2B1 MYH14 ACLY TBPL1 SLC25A1 MCM3AP GARS1 SMC4 PLOD1 MOV10 | 7.99e-06 | 1353 | 77 | 13 | 29467282 |
| Pubmed | 9.02e-06 | 217 | 77 | 6 | 30619736 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 9.38e-06 | 333 | 77 | 7 | 32665550 | |
| Pubmed | 9.61e-06 | 469 | 77 | 8 | 37314180 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 9.91e-06 | 624 | 77 | 9 | 33729478 | |
| Pubmed | 1.11e-05 | 803 | 77 | 10 | 36517590 | ||
| Pubmed | 1.12e-05 | 131 | 77 | 5 | 28634551 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.16e-05 | 344 | 77 | 7 | 30333137 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 MYH10 AP2B1 ACLY SLC25A1 GARS1 USP24 SMC4 SNRNP70 PLOD1 HECTD1 LRRC8D YARS1 | 1.29e-05 | 1415 | 77 | 13 | 28515276 |
| Pubmed | Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons. | 1.35e-05 | 21 | 77 | 3 | 25168025 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.42e-05 | 235 | 77 | 6 | 30258100 | |
| Pubmed | De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus. | 1.45e-05 | 3 | 77 | 2 | 29983323 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 28821574 | ||
| Interaction | EED interactions | MYH9 MYH10 MYH11 AP2B1 VILL NSF BAZ2B ACLY GARS1 SMC4 TRIM71 SSR3 SNRNP70 PLXNB2 PLOD1 HECTD1 VPS53 MOV10 | 2.79e-06 | 1445 | 73 | 18 | int:EED |
| Interaction | TERF2 interactions | 3.74e-06 | 340 | 73 | 9 | int:TERF2 | |
| Interaction | ABCA9 interactions | 5.37e-06 | 10 | 73 | 3 | int:ABCA9 | |
| Interaction | SHC1 interactions | 6.22e-06 | 362 | 73 | 9 | int:SHC1 | |
| Interaction | LRRC31 interactions | 9.39e-06 | 205 | 73 | 7 | int:LRRC31 | |
| Interaction | WDFY4 interactions | 1.22e-05 | 141 | 73 | 6 | int:WDFY4 | |
| Interaction | SIRT7 interactions | MYH9 MYH10 AP2B1 MYH14 ACLY MCM3AP USP24 SMC4 SNRNP70 PLOD1 HECTD1 MOV10 | 1.36e-05 | 744 | 73 | 12 | int:SIRT7 |
| Interaction | ECT2 interactions | CWF19L2 MYH9 MYH10 MYH11 AP2B1 MYH14 ABCA13 ACLY SNRNP70 PLOD1 HECTD1 DNAH9 MOV10 | 1.59e-05 | 887 | 73 | 13 | int:ECT2 |
| Interaction | SNAI1 interactions | 2.63e-05 | 546 | 73 | 10 | int:SNAI1 | |
| Interaction | LMBR1L interactions | GORASP2 MYH11 NSF ACLY SLC25A1 USP24 SMC4 PTDSS2 SSR3 PLXNB2 PLOD1 HECTD1 VPS53 | 3.11e-05 | 946 | 73 | 13 | int:LMBR1L |
| Interaction | NR2C2 interactions | MYH9 MYH10 NSF ACLY TBPL1 NT5DC2 SLC25A1 GARS1 USP24 TNRC6A SMC4 SSR3 SNRNP70 PLOD1 YARS1 MOV10 | 3.33e-05 | 1403 | 73 | 16 | int:NR2C2 |
| Interaction | SIK2 interactions | 4.14e-05 | 106 | 73 | 5 | int:SIK2 | |
| Interaction | DPM2 interactions | 4.37e-05 | 54 | 73 | 4 | int:DPM2 | |
| Interaction | MYL12A interactions | 6.93e-05 | 192 | 73 | 6 | int:MYL12A | |
| Interaction | PPP5D1P interactions | 7.73e-05 | 4 | 73 | 2 | int:PPP5D1P | |
| Interaction | MYL3 interactions | 9.90e-05 | 25 | 73 | 3 | int:MYL3 | |
| Interaction | TRIM66 interactions | 9.94e-05 | 205 | 73 | 6 | int:TRIM66 | |
| Interaction | FGD5 interactions | 1.05e-04 | 207 | 73 | 6 | int:FGD5 | |
| Interaction | RABL6 interactions | 1.09e-04 | 130 | 73 | 5 | int:RABL6 | |
| Interaction | PDE4B interactions | 1.15e-04 | 69 | 73 | 4 | int:PDE4B | |
| Interaction | MYH11 interactions | 1.35e-04 | 136 | 73 | 5 | int:MYH11 | |
| Interaction | TRMT2A interactions | 1.50e-04 | 139 | 73 | 5 | int:TRMT2A | |
| Interaction | NQO2 interactions | 2.10e-04 | 32 | 73 | 3 | int:NQO2 | |
| Interaction | TMPRSS2 interactions | 2.17e-04 | 337 | 73 | 7 | int:TMPRSS2 | |
| GeneFamily | ATP binding cassette subfamily A | 6.44e-08 | 14 | 53 | 4 | 805 | |
| GeneFamily | Myosin heavy chains | 8.77e-08 | 15 | 53 | 4 | 1098 | |
| GeneFamily | Dyneins, axonemal | 1.11e-03 | 17 | 53 | 2 | 536 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-07 | 173 | 77 | 6 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-07 | 181 | 77 | 6 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 197 | 77 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 199 | 77 | 6 | 7b21447bb39cdba37539a12cb475f463010fc23f | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.76e-06 | 77 | 77 | 4 | ebb1a537751739232820a60f88911877fc683855 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 175 | 77 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 175 | 77 | 5 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 175 | 77 | 5 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 178 | 77 | 5 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 178 | 77 | 5 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 179 | 77 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-05 | 181 | 77 | 5 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.56e-05 | 181 | 77 | 5 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 184 | 77 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-05 | 184 | 77 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-05 | 185 | 77 | 5 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-05 | 186 | 77 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 187 | 77 | 5 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 188 | 77 | 5 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-05 | 189 | 77 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 190 | 77 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.07e-05 | 192 | 77 | 5 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.34e-05 | 197 | 77 | 5 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.40e-05 | 198 | 77 | 5 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 2.40e-05 | 198 | 77 | 5 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-05 | 198 | 77 | 5 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | 3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.46e-05 | 199 | 77 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 2.52e-05 | 200 | 77 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.37e-05 | 137 | 77 | 4 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 141 | 77 | 4 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.14e-04 | 144 | 77 | 4 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.55e-04 | 156 | 77 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 157 | 77 | 4 | d12f343454202da86a06d0369f8ffe5662cd091b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 160 | 77 | 4 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 160 | 77 | 4 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 162 | 77 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 163 | 77 | 4 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 167 | 77 | 4 | b742558ca92985db0a67c88f530bc375f3d3bb98 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.10e-04 | 169 | 77 | 4 | 0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-04 | 170 | 77 | 4 | 32917888c3f1d54302675c1d4de1fd3b7c79af5f | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.20e-04 | 171 | 77 | 4 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 174 | 77 | 4 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 175 | 77 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 175 | 77 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 177 | 77 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 177 | 77 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 178 | 77 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-04 | 179 | 77 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-04 | 179 | 77 | 4 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 180 | 77 | 4 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-04 | 180 | 77 | 4 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 180 | 77 | 4 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-04 | 180 | 77 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 181 | 77 | 4 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-04 | 181 | 77 | 4 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | HSPCs-Erythroblasts|HSPCs / Lineage and Cell class | 2.73e-04 | 181 | 77 | 4 | 4ded490f190af7ace343acdf317edc7373484d08 | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 2.73e-04 | 181 | 77 | 4 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 182 | 77 | 4 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 182 | 77 | 4 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-04 | 183 | 77 | 4 | 7733cf919eda146efe41c93990658ce92db73aa8 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-04 | 183 | 77 | 4 | d91441cbf94f5c3b7c36f2ca3a46895870bd730f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 184 | 77 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 185 | 77 | 4 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-04 | 185 | 77 | 4 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.96e-04 | 185 | 77 | 4 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-04 | 186 | 77 | 4 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-04 | 186 | 77 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-04 | 186 | 77 | 4 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 187 | 77 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 3.09e-04 | 187 | 77 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-04 | 187 | 77 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-04 | 187 | 77 | 4 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.09e-04 | 187 | 77 | 4 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| Drug | purealin | 1.54e-06 | 58 | 77 | 5 | CID006419303 | |
| Drug | verapamil | MYH9 MYH10 MYH11 MYH14 ABCA12 ABCA13 ASIC5 ABCA10 ABCA9 ABCC10 | 5.87e-06 | 490 | 77 | 10 | CID000002520 |
| Disease | Charcot-Marie-Tooth disease | 1.56e-04 | 42 | 73 | 3 | cv:C0007959 | |
| Disease | lung volume | 1.67e-04 | 8 | 73 | 2 | EFO_0600046 | |
| Disease | mean arterial pressure | 2.36e-04 | 499 | 73 | 7 | EFO_0006340 | |
| Disease | cortical surface area measurement | MYH10 NSF BAZ2B NT5DC2 TNRC6A TRIM71 ARHGAP28 PTCH1 BCR PLXNB2 MOV10 | 4.49e-04 | 1345 | 73 | 11 | EFO_0010736 |
| Disease | hyperglycemia (is_marker_for) | 4.63e-04 | 13 | 73 | 2 | DOID:4195 (is_marker_for) | |
| Disease | asthma | 5.31e-04 | 751 | 73 | 8 | MONDO_0004979 | |
| Disease | Diuretic use measurement | 8.31e-04 | 169 | 73 | 4 | EFO_0009928 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 1.00e-03 | 19 | 73 | 2 | OBA_2045199 | |
| Disease | reticulocyte count | 1.08e-03 | 1045 | 73 | 9 | EFO_0007986 | |
| Disease | visual cortical surface area measurement | 1.11e-03 | 20 | 73 | 2 | EFO_0004771 | |
| Disease | macula measurement | 1.26e-03 | 189 | 73 | 4 | EFO_0008375 | |
| Disease | birth weight, parental genotype effect measurement | 1.33e-03 | 192 | 73 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 1.61e-03 | 24 | 73 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Hyalinosis, Segmental Glomerular | 2.19e-03 | 28 | 73 | 2 | C0086432 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.35e-03 | 29 | 73 | 2 | cv:C5779548 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNSNKAQFKLRIFSF | 1191 | Q5DID0 | |
| KIITIGLFFSNFERN | 541 | P16452 | |
| NKFQVITGQRVFVFR | 346 | Q8WWN8 | |
| TDFAIQFNKNSFGVI | 751 | P63010 | |
| KGFVAFQAAINAAII | 86 | Q8WWZ4 | |
| FQKLASQLGVYRAFV | 581 | P11274 | |
| KGFVAFQAAINAAII | 176 | Q8IUA7 | |
| TLRNPFVQVFVKFSV | 866 | Q86UK0 | |
| VRRAQFTFFNKTGLF | 741 | Q86SQ4 | |
| VVQFLRNFGKVLGFD | 1096 | Q9UIF8 | |
| VIVAFQLTAFTFRKN | 4521 | Q86UQ4 | |
| LVRAAKQLNFVFTGR | 511 | Q9Y2Q0 | |
| GIQKFRAFVLVSNFQ | 416 | Q8IWA6 | |
| ANAFIQAGIFQEFKV | 61 | O60671 | |
| NFKVNQRRFVTFSQG | 556 | Q7Z5J8 | |
| QFATIRDNILFGKTF | 676 | Q5T3U5 | |
| KVLDIFENQGFFQLV | 1066 | Q96RG2 | |
| RIQIFTFEGQFLLKF | 676 | Q2Q1W2 | |
| FFDFIVSINGSRLNK | 36 | Q9H8Y8 | |
| VFTFIFGLLNANRRK | 491 | P59045 | |
| VGPSFVRKEFQNNFV | 71 | Q8WWW8 | |
| FNIQKRPFAVTTQSF | 236 | Q96PV6 | |
| ALNSNNFVRFFKLVQ | 846 | O60318 | |
| NDNSSRFGKFIRINF | 256 | Q7Z406 | |
| LSVKGTLQQFVDNFF | 1626 | O15031 | |
| NQEFSFGNLRAKFLR | 356 | Q2TBE0 | |
| SVGQQLVFSFNEKLF | 131 | P46459 | |
| NSSRFGKFIRINFDV | 231 | P35579 | |
| KFQPFNVAVSSNVLF | 266 | Q8N594 | |
| NQTFVSKFIFLGLSQ | 21 | Q8NGH3 | |
| GFTIQVFTKNQRISF | 126 | P29728 | |
| RSAQFFNYKIQALGL | 46 | Q02809 | |
| QAFLTGTLQNFARKF | 4121 | Q9P2D7 | |
| FVRLFTQLKFGVVQT | 101 | P51797 | |
| QFQSISLRKIQFNFP | 216 | P51797 | |
| FVFVRKLREGQNFIF | 1051 | Q9ULT8 | |
| GTEKVQFVVRFIFNL | 46 | P13765 | |
| FQTTKLNGFEVFARF | 356 | P06756 | |
| PVAVKVFSFANRQNF | 226 | Q13873 | |
| IVEFIRNKGFYLNNS | 166 | Q9NY37 | |
| REFVAGFVQFRVFNN | 241 | Q8WWU7 | |
| VFQITLRKGYQIQDF | 2846 | Q9NYC9 | |
| RQGFFLQQVVFASLA | 481 | A6NKX4 | |
| QILFLGFNFRKNFGI | 286 | Q13183 | |
| VLIQVFKEFNFNLGE | 306 | Q7RTP0 | |
| FQQGFFRNKILVIAI | 956 | P20648 | |
| NDNSSRFGKFIRINF | 236 | P35580 | |
| GRKTNLDFQQYVFIN | 136 | Q7L1W4 | |
| QFVAKASVFIVVRNA | 146 | Q8NGH5 | |
| QFCIQRFINFVVKLG | 246 | Q9BXD5 | |
| RFINFVVKLGFGVSQ | 251 | Q9BXD5 | |
| RLQNQFLKGLSEFFR | 271 | Q5HYW3 | |
| NAQGDAFKTLFVARV | 96 | P08621 | |
| AQFGGIDQRKIFTFA | 181 | P54577 | |
| ISHFGENIKQFFQTI | 1006 | B4DYI2 | |
| RFVDGLTFKVNFTFN | 436 | Q9HCE1 | |
| FILFQTVQDGRQFLK | 141 | Q9BVG9 | |
| AQGIFLNFKRLLEFN | 301 | P41250 | |
| RAFSLQAAVVVVFNF | 571 | Q13635 | |
| VAISIFQGNSAAFKI | 241 | O43699 | |
| LLAEQNRGQFFTVYK | 1081 | Q9Y2G9 | |
| VASFFILKNFNPTVN | 151 | Q9UNL2 | |
| NFTNVAATFKGIVRA | 346 | P53396 | |
| KFVNFLLVNGFQTAI | 426 | O43734 | |
| AFRAGLKVSFANFIQ | 291 | Q9NRB3 | |
| NDNSSRFGKFIRINF | 236 | P35749 | |
| RSLQKLGFQVIFTDF | 86 | P62380 | |
| AGFIQFAQLQFLEAK | 356 | Q8WUH2 | |
| LTAFFDAFGIQLKRN | 351 | Q9P2N2 | |
| KIQDRIGFFPANFVQ | 326 | Q99469 | |
| ATVLKQGSNQAIRFF | 186 | P53007 | |
| NFLKRQNIGVATFIG | 656 | Q9NTJ3 | |
| ITKALFNAQFGSIFR | 436 | Q9H857 | |
| QFRIVLGDFNFAGIQ | 446 | Q9NZM6 | |
| FAIQRTTNFEGFLAK | 346 | Q5VIR6 | |
| FLAIFQGQLVIFQER | 481 | O15195 | |
| FNRTNKFTAGFQNIV | 366 | Q9HBG4 | |
| FLFNTFVQKQGIRAG | 2286 | Q9UPU5 | |
| INPFVKQFSNISFSR | 1201 | Q8NDV7 |